Shenzhen Weiguang Biological Products Co Ltd (002880) — Strategic Asset Allocation Index
Shenzhen Weiguang Biological Products Co Ltd (002880) has a Strategic Asset Allocation Index of 56.7% as of September 2023. Strategic assets (PP&E of CN¥1.12 Billion plus long-term investments of CN¥-) total CN¥1.12 Billion, measured against net assets of CN¥1.97 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of Shenzhen Weiguang Biological Products Co to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Shenzhen Weiguang Biological Products Co Ltd Strategic Asset Allocation Index (2016–2021)
This chart shows how Shenzhen Weiguang Biological Products Co Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of September 2023, the index stands at 56.7%, representing strategic assets of CN¥1.12 Billion against net assets of CN¥1.97 Billion CNY. See how financially flexible is Shenzhen Weiguang Biological Products Co to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Shenzhen Weiguang Biological Products Co Ltd (2016–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Shenzhen Weiguang Biological Products Co Ltd from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Shenzhen Weiguang Biological Products Co.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 43.9% | CN¥785.22 Million | CN¥785.22 Million | CN¥- | CN¥1.79 Billion | ▲ +9.1 pp |
| 2020 | 34.8% | CN¥565.30 Million | CN¥565.30 Million | CN¥- | CN¥1.62 Billion | ▲ +3.9 pp |
| 2019 | 30.9% | CN¥447.87 Million | CN¥447.87 Million | CN¥- | CN¥1.45 Billion | ▼ -1.6 pp |
| 2018 | 32.5% | CN¥424.27 Million | CN¥424.27 Million | CN¥- | CN¥1.31 Billion | ▼ -0.2 pp |
| 2017 | 32.6% | CN¥392.75 Million | CN¥392.75 Million | CN¥- | CN¥1.20 Billion | ▼ -41.2 pp |
| 2016 | 73.9% | CN¥374.02 Million | CN¥374.02 Million | CN¥- | CN¥506.44 Million | — |